Korean J Fam Pract. 2018; 8(4): 601-606  https://doi.org/10.21215/kjfp.2018.8.4.601
Factors Associated with Smoking Cessation
Kyoungman Jung, Byoungduck Han*, Sung Jung Cho, Ga Eun Nam, Dohyun Eum, Junghoon Kim, Taeryun Kim, Sangwoo Lee
Department of Family Medicine, Sahmyook Medical Center, Seoul, Korea
Byoungduck Han Tel: +82-2-2210-3245, Fax: +82-2-2212-2673 E-mail: arybury1@naver.com ORCID: http://orcid.org/0000-0003-2830-1174
Received: July 6, 2017; Revised: September 6, 2017; Accepted: September 11, 2017; Published online: August 20, 2018.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Since 2015, the government has supported smoking cessation treatment through the National Health Insurance in order to reduce smoking rates. The purpose of this study was to establish a successful smoking cessation rate and identify factors related to successful smoking cessation.
Methods: Fifty-four participants who visited the SahmYook Medical Center Smoking Cessation Clinic between March 2016 and January 2017 completed a questionnaire detailing general characteristics, such as sex, age, and body mass index; smoking-related questions, such as smoking amount, smoking duration, and nicotine dependency; and psychological factors, such as depression and stress. IBM SPSS Statistics ver. 22.0 software was used for statistical data analysis, including the chi-square test and the Mann-Whitney U-test. The statistical significance is defined as P<0.05.
Results: A logistic regression was performed based on the results of univariate analysis. Results revealed that participants having depressive symptoms tended to achieve a lower smoking cessation rate than those without the symptoms. Other variables did not produce significant results.
Conclusion: The participants of the smoking cessation treatment through the National health Insurance are increasing. To maximize the effectiveness of the smoking cessation treatment, psychological factors, such as depressive mood as well as medication should be considered.
Keywords: Smoking Cessation; Beck Depression Inventory; Depressive Symptoms; Varenicline
  1. Benowitz NL. Nicotine addiction. N Engl J Med 2010; 362: 2295-303.
    Pubmed KoreaMed CrossRef
  2. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004;96: 99-106.
    Pubmed CrossRef
  3. World Health Organization. WHO Report on the Global Tobacco Epidemic Warning about the Dangers of Tobacco. Geneva: World Health Organization;2011.
  4. Organization for Economic Cooperation and Development. Non-medical determinants of health (edition 2016) [Internet]. Paris: OECD Health Statistics;2016. [cited 2017 Mar 29].
  5. Korea Centers for Disease Control and Prevention. Health behavior and chronic disease statistics 2015 [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2015. [cited 2016 Nov 10].
  6. Lee JS, Kang SM, Kim HJ, Lee KY, Cho B, Goh E. Long-term maintenance of smoking cessation and related factors of relapse. Korean J Fam Med 2009;30: 203-9.
  7. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2008; (2): CD000165.
  8. Kim Y, Cho WK. Factors associated with successful smoking cessation in Korean adult males: findings from a national survey. Iran J Public Health 2014; 43: 1486-96.
    Pubmed KoreaMed
  9. Kim YJ. Predictors for successful smoking cessation in Korean adults. Asian Nurs Res (Korean Soc Nurs Sci) 2014; 8: 1-7.
    Pubmed CrossRef
  10. Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997; 6 Suppl 2: S57-62.
    Pubmed KoreaMed CrossRef
  11. Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health 2007; 97: 1503-9.
    Pubmed KoreaMed CrossRef
  12. Derby CA, Lasater TM, Vass K, Gonzalez S, Carleton RA. Characteristics of smokers who attempt to quit and of those who recently succeeded. Am J Prev Med 1994; 10: 327-34.
  13. Yang MY, Ahn KM, Sohn AR. The effects of a smoking cessation program on stress and emotional status of the Korean male office workers. Journal of the Korea Academia-Industrial Cooperation Society 2013; 14: 6364-72.
  14. Borland R, Owen N, Hill D, Schofield P. Predicting attempts and sustained cessation of smoking after the introduction of workplace smoking bans. Health Psychol 1991; 10: 336-42.
    Pubmed CrossRef
  15. Hennrikus DJ, Jeffery RW, Lando HA. The smoking cessation process: longitudinal observations in a working population. Prev Med 1995; 24: 235-44.
    Pubmed CrossRef
  16. Kim CH, Seo HG. The factors associated with success of smoking cessation at smoking-cessation clinic. J Korean Acad Fam Med 2001; 22: 1603-11.
  17. Song TM, Lee JY, Choi KS. The factors influencing on success of quitting smoking in new enrollees and re-enrollees in smoking cessation clinics. Journal of Korean Society for Health Education and Promotion 2008; 25:19-30.
  18. Berlin I, Covey LS. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction 2006; 101:1814-21.
    Pubmed CrossRef
  19. Pawlina MM, Rondina Rde C, Espinosa MM, Botelho C. Depression, anxiety, stress, and motivation over the course of smoking cessation treatment. J Bras Pneumol 2015; 41: 433-9.
    Pubmed KoreaMed CrossRef
  20. Chaiton M, Cohen JE, Rehm J, Abdulle M, O’Loughlin J. Confounders or intermediate variables? Testing mechanisms for the relationship between depression and smoking in a longitudinal cohort study. Addict Behav 2015;42: 154-61.
    Pubmed CrossRef
  21. Fagerström K, Hughes J. Varenicline in the treatment of tobacco dependence. Neuropsychiatr Dis Treat 2008; 4: 353-63.
    Pubmed KoreaMed CrossRef
  22. Choi MK, Paek YJ. Updated information on smoking cessation management. J Korean Med Assoc 2016; 59: 872-80.
  23. Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction 2008; 103: 146-54.
    Pubmed CrossRef
  24. Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, Galvan G, Diaz-Mesa E, Bobes-Bascaran T, et al. It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline. Schizophr Res 2016; 176:272-80.
    Pubmed CrossRef
  25. Fact sheet: Development of the Stress Questionnaire for KNHANES [Internet]. Cheongju: Korea Center for Disease Control and Prevention [cited 2011 Sep 6].
  26. Babor TF, Higgins-Biddle JC, World Health Organization. Brief intervention for hazardous and harmful drinking : a manual for use in primary care. Geneva: World Health Organization; 2001.
  27. Son HK, Jung UY, Park KS, Kam S, Park SK, Lee WK. The factors implicated when an individual starts to smoke again after a 6 month cessation. J Prev Med Public Health 2009; 42: 42-8.
    Pubmed CrossRef
  28. Kim HS, Bae SS. Factors associated with relapse to smoking behavior using health belief model. J Agric Med Community Health 2011; 36: 87-100.

This Article